View in EDS HTML Full Text PDF Full Text

MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.

Saved in:
Bibliographic Details
Title: MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.
Authors: Wyce A; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Matteo JJ; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Foley SW; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Felitsky DJ; Target Sciences, GlaxoSmithKline, Upper Merion, PA, USA., Rajapurkar SR; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Zhang XP; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Musso MC; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Korenchuk S; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Karpinich NO; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Keenan KM; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Stern M; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Mathew LK; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., McHugh CF; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., McCabe MT; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Tummino PJ; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.; Janssen Pharmaceuticals, Spring House, Montgomery, PA, USA., Kruger RG; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Carpenter C; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA., Barbash O; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA. olena.x.barbash@gsk.com.
Source: Oncogenesis [Oncogenesis] 2018 Apr 20; Vol. 7 (4), pp. 35. Date of Electronic Publication: 2018 Apr 20.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101580004 Publication Model: Electronic Cited Medium: Print ISSN: 2157-9024 (Print) Linking ISSN: 21579024 NLM ISO Abbreviation: Oncogenesis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29674704
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wyce+A%22">Wyce A</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Matteo+JJ%22">Matteo JJ</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Foley+SW%22">Foley SW</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Felitsky+DJ%22">Felitsky DJ</searchLink>; Target Sciences, GlaxoSmithKline, Upper Merion, PA, USA.<br /><searchLink fieldCode="AU" term="%22Rajapurkar+SR%22">Rajapurkar SR</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+XP%22">Zhang XP</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Musso+MC%22">Musso MC</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Korenchuk+S%22">Korenchuk S</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Karpinich+NO%22">Karpinich NO</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Keenan+KM%22">Keenan KM</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Stern+M%22">Stern M</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mathew+LK%22">Mathew LK</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22McHugh+CF%22">McHugh CF</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22McCabe+MT%22">McCabe MT</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Tummino+PJ%22">Tummino PJ</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.; Janssen Pharmaceuticals, Spring House, Montgomery, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kruger+RG%22">Kruger RG</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Carpenter+C%22">Carpenter C</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Barbash+O%22">Barbash O</searchLink>; Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA. olena.x.barbash@gsk.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101580004%22">Oncogenesis</searchLink> [Oncogenesis] 2018 Apr 20; Vol. 7 (4), pp. 35. <i>Date of Electronic Publication: </i>2018 Apr 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101580004 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2157-9024 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221579024%22">21579024 </searchLink><i>NLM ISO Abbreviation: </i>Oncogenesis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29674704
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41389-018-0043-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 35
    Titles:
      – TitleFull: MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wyce A
      – PersonEntity:
          Name:
            NameFull: Matteo JJ
      – PersonEntity:
          Name:
            NameFull: Foley SW
      – PersonEntity:
          Name:
            NameFull: Felitsky DJ
      – PersonEntity:
          Name:
            NameFull: Rajapurkar SR
      – PersonEntity:
          Name:
            NameFull: Zhang XP
      – PersonEntity:
          Name:
            NameFull: Musso MC
      – PersonEntity:
          Name:
            NameFull: Korenchuk S
      – PersonEntity:
          Name:
            NameFull: Karpinich NO
      – PersonEntity:
          Name:
            NameFull: Keenan KM
      – PersonEntity:
          Name:
            NameFull: Stern M
      – PersonEntity:
          Name:
            NameFull: Mathew LK
      – PersonEntity:
          Name:
            NameFull: McHugh CF
      – PersonEntity:
          Name:
            NameFull: McCabe MT
      – PersonEntity:
          Name:
            NameFull: Tummino PJ
      – PersonEntity:
          Name:
            NameFull: Kruger RG
      – PersonEntity:
          Name:
            NameFull: Carpenter C
      – PersonEntity:
          Name:
            NameFull: Barbash O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 04
              Text: 2018 Apr 20
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 2157-9024
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Oncogenesis
              Type: main
ResultId 1